Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Thank you for visiting us at EBF Open Symposium 2025

Poster Downloads

A Fully Automated Workflow for Gyrolab Assays

A Fully Automated Workflow for Gyrolab Assays

AlphaLISA Automation for PK Assays: Boosting Throughput While Ensuring Robustness and Precision

AlphaLISA Automation for PK Assays: Boosting Throughput While Ensuring Robustness and Precision

Enhancing Robustness in Hybridization ECLIA for Sensitive Quantification of siRNA Therapeutics in Human Plasma

Enhancing Robustness in Hybridization ECLIA for Sensitive Quantification of siRNA Therapeutics in Human Plasma

Please find below some of our latest resources, which highlight our experience and expertise as a full-service early-phase CRO.

Fact Sheet


Celerion Overview

Learn More

Fact Sheet


Leaders in Bioequivalence & Bioavailability Studies

Learn More

Fact Sheet


Leverage Our Renal/Hepatic PK Study Experience & Expertise

Learn More

Fact Sheet


Expert Drug-Drug Interaction Study Design and Conduct

Learn More

Fact Sheet


Food Effect Study Best Practices

Learn More

Video


Unlocking Value of Flow Cytometry During Drug Development

Learn More

Video


Nitrosamine Impurities in Rifampin

Learn More

White Paper


Perpetrator or Victim: Evaluating Therapeutic Proteins in Drug-Drug Interaction Studies

Learn More

White Paper


Women’s Health: Maximizing Study Design of Combined Oral Contraceptives Drug Interaction Studies

Learn More

Fill out this form for more information on our services.

For additional marketing literature and thought leadership content please visit our Resource Center.